Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Daewoong Pharmaceutical Co. Ltd.

www.daewoong.com

Latest From Daewoong Pharmaceutical Co. Ltd.

Daewoong's P-CAB Contender Holds Up Well At Phase III

South Korean firm presents encouraging Phase III data for its novel P-CAB drug fexuprazan at Digestive Disease Week and hopes the results will accelerate entry into global markets.   

South Korea Clinical Trials

Deal Watch: Novartis Partners With TScan To Develop T-Cell Receptor-Targeted Therapies

Novartis/TScan and Gilead/Kite/oNKo-innate partnerships seek to advance cancer cell therapy. J&J, Bayer among the latest pharmas to unveil partnerships to fight the novel coronavirus.

Deals Business Strategies

Medytox Faces Botulinum Approval Cancellation Over Data Issues

Leading South Korean botulinum toxin company Medytox is facing substantial business risk as its Meditoxin product is suspended amid test result manipulation investigations.

South Korea Approvals

Coronavirus Update: Remedesivir China Trials Halted, Witty To Spearhead WHO's Vaccines Efforts

Plus: Korean firms working on repurposed drug which showed far higher efficacy than remdesivir and chloroquine in pre-clinical tests

Coronavirus COVID-19 Infectious Diseases
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • Daewoong Pharmaceutical Co. Ltd.
  • Senior Management
  • Sengho Jeon, CEO
  • Contact Info
  • Daewoong Pharmaceutical Co. Ltd.
    Phone: (82) 2 550 8533
    Bongeunsa-ro114-gil 12
    Gangnam-gu
    Seoul, 135 715
    South Korea
UsernamePublicRestriction

Register